Skip to content

The Effects of Inhalation of Rosa Damascene Essential Oil on Fatigue and Anxiety among Cancer Patients Receiving Chemotherapy

The Effects of Inhalation of Rosa Damascene Essential Oil on Fatigue and Anxiety among Cancer Patients Receiving Chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20111015007803N3
Enrollment
64
Registered
2018-08-29
Start date
2018-04-20
Completion date
Unknown
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

People with cancer under chemotherapy. Malignant neoplasm, unspecified

Interventions

Intervention 1: The fatigue and anxiety levels of the patients were assessed by a researcher before intervention using the BFI and Spielberger questionnaires. by the assistant Using a pipette, d

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age greater than 18 and less than 70 years Cancer patients with at least one chemotherapy course with a 21 day interval from the last session. Detect stage 2, 3, and 4 of all cancers other than head and neck and lung with the opinion of the relevant physician. Full vigilance No history of cigarette and drug addiction Earning a score higher than 20 after responding to the Spielberger questionnaire in the pre-test Non-use of benzodiazepines, tranquillizers and opioids during intervention Without a history of migraine and chronic headaches Non-impaired sense of smell (without obstruction and nasal congestion) and healthy sense of smell) through smelling of alcohol). Inability of the patient to answer questions (in terms of physical and mental status) lack of patient psychiatric problems (hospitalization or other medical treatment is not due to mental disorders). Stable and stable hemodynamic status Not having a history of allergy to the smell of herbs and any scent or fragrance Not having respiratory diseases The desire to participate in research Do not use any other scent during the study

Exclusion criteria

Exclusion criteria: Patients with head and neck cancer

Design outcomes

Primary

MeasureTime frame
Fatigue of patients with cancer under chemotherapy. Timepoint: Before the intervention and 30, 60 minutes after the intervention for three consecutive days. Method of measurement: Standard Fatigue Fatigue Questionnaire (BFI).;Anxiety in patients with cancer under chemotherapy. Timepoint: Before the intervention and 20 minutes after the intervention for three consecutive days. Method of measurement: Spilberger Situational Anxiety Inventory.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Khosrobeigi

Arak University of Medical Sciences

elhamkhosrobeigi65@yahoo.com+98 634120497

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026